A study for the Relationship between Vitamin K2 and Health Effects of Bone and Blood Vessel

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800019240

Enrollment

Unknown

Registered

2018-11-01

Start date

2018-11-01

Completion date

Unknown

Last updated

2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

Vitamin K2 group:Vitamin K2

Placebo group:Placebo

VKDCa1:Vitamin K2,ca,vitamin D

VKDCa2:Vitamin K2,ca,vitamin D

Eligibility

Sex/Gender

All

Age

35 Years to 85 Years

Inclusion criteria

Inclusion criteria: T score of lumbar spine and hip =-1, but =-2.5

Exclusion criteria

Exclusion criteria: 1. suffering from cancer, genetic diseases, hyperthyroidism, psychosis, type 1 diabetes, stroke; 2. With heart, liver, kidney and other functional failure; 3. Physical disabilities can not walk; 4. Intake drugs that affect the study and vitamin K2 supplements within six months.

Design outcomes

Primary

Measure	Time frame
Bone mineral density;Osteocalcin;bone-specific alkaline phosphatase;	—

Secondary

Measure	Time frame
MGP;CCA-IMT;	—

Countries

China

Contacts

Public ContactLi Ying

Harbin Medical University

liying_helen@163.com+86 18245132681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026